Ainos, Inc. operates as a diversified medtech company focused on pharmaceuticals, medical devices, and preventive medicine. Its pharmaceutical division develops low-dose interferon solutions aimed at improving patient outcomes for diseases such as Thrombocytopenia and Sjogren’s Syndrome. The medical devices segment creates AI-driven, telehealth-compatible point-of-care testing solutions, including diagnostics for COVID-19 and other health conditions. Ainos also explores the applications of mRNA technology for vaccine development and treatments in oncology and inflammatory diseases, leveraging its extensive research and patent portfolio. The company operates primarily in the United States and Taiwan.
No recent RNS announcements for AIMD across AIMD, AIMDW.
No recent RNS announcements for AIMD across AIMD, AIMDW.